Skip to main content

Morning Update

Yesterday stocks traded in a tight range on exceptionally low volume ahead of a series of central bank meetings this week. NYSE total volume was two standard deviations below average and the lowest volume put in on a non-holiday trading day this year (zerohedge).

Recent consumer confidence data out of Germany, Finland, Austria, and France came in weak, showing that the continent’s banking crisis is beginning to impact consumers in even the strongest European economies. This pessimism indicates that Europe is unlikely to quickly pick up in the coming months (Wall Street Journal). Europeans certainly have plenty to worry about with Euro-zone unemployment at 11.2% with 123,000 jobs being shed in June. This poor data will likely be supportive of ECB intervention in some capacity, which could be announced as early as Thursday.

Reports out of the US this morning were a bit more upbeat: the Case-Shiller home price index rose 0.7%, an unusually large gain and the third monthly gain in a row.

Pfizer reported a Q2 earnings beat this morning with EPS of $0.62 versus $0.54 expected. Global revenue fell 9% but still managed to beat expectations. Earnings growth was driven by better than expected sales of Lipitor coupled with decreases in research spending and administrative costs. The company also announced plans to separate its animal health division into a standalone company so that it can concentrate on its core pharmaceuticals business (Reuters). This stock yields 3.71% and has outperformed the broad market year to date. We remain bullish on the stock going forward, which is likely to see price appreciation due to its yield and earnings stability.

Comments

Popular posts from this blog

Morning Update

Yesterday JC Penny reported what some are calling “The Worst Quarter in the History of Retail.” The company reported a quarterly loss of $2.51 per shares and that revenue dropped 24.8%. Revenue at stores open for at least a year fell 31.7% and customer traffic dropped 17% last quarter following a 10% decrease in third quarter. Not surprisingly these dismal numbers spurred option traders to make some large bearish bets on the stock. The biggest was the purchase of 30,000 May 16 puts for $1.57 with the stock at 17.50. This trade will be profitable if JCP is below 14.43, 17.5% lower, by May expiration. One of the biggest concerns investors should have in JC Penny’s cash supply. In November they told investors that they would end the year with $1 billion in cash, but ended up with only $930 million. Wednesday they then told investors that they had delayed $85 million in payments to their suppliers until the early part of the first quarter. This is another red flag that the company is run...